Narushenie metabolizma kal'tsiya posle bariatricheskikh vmeshatel'stv (lektsiya dlya vrachey)
- Authors: Troshina E.A1, Mazurina N.V1, Ogneva N.A1, Yashkov Y.I2
-
Affiliations:
- ФГБУ Эндокринологический научный центр Минздрава России, Москва
- ЗАО Центр эндохирургии и литотрипсии, Москва
- Issue: Vol 16, No 4 (2014)
- Pages: 72-74
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94077
- ID: 94077
Cite item
Full Text
Abstract
На сегодняшний день наиболее эффективным методом лечения при морбидном ожирении (индекс массы тела более 40 кг/м2) является бариатрическая хирургия Нарушения кальциевого обмена в той или иной степени определяются после всех бариатрических вмешательств, однако выраженные изменения прису щи в первую очередь шунтирующим процедурам. Таким образом, всем пациентам, перенесшим бариатрические операции, показаны пожизненное наблюдение и регулярный прием комплекса витаминов и микроэлементов, всем больным, страдающим морбидным ожирением, планирующим и перенесшим бариатрические операции, необходим тщательный мониторинг состояния кальциевого обмена для предупреждения развития тяжелой костной патологии.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
E. A Troshina
ФГБУ Эндокринологический научный центр Минздрава России, Москва
N. V Mazurina
ФГБУ Эндокринологический научный центр Минздрава России, Москва
N. A Ogneva
ФГБУ Эндокринологический научный центр Минздрава России, Москва
Yu. I Yashkov
ЗАО Центр эндохирургии и литотрипсии, Москва
References
- Aasheim E, Hofso D, Hjelmesaeth J et al. Vitamin status in morbidly obese patients: a cross - sectional study. Am J Clin Nut 2008; 87: 362-9.
- American association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic and non - surgical support of the bariatric surgery patient. Surg Obes Relat Dis 2008; 4 (Suppl. 5): S109-84.
- Arunabh S, Pollak S, Yeh J et al. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003; 88: 157-61.
- Atreja A, Abacan C, Licata A. A 51-year - old woman with debilitating cramps 12 years after bariatric surgery. Clev Clin J Med 2003; 70: 417-26.
- Bano G, Rodin D, Pazianas M et al. Reduced bone mineral density after surgical treatment for obesity. Int J Obes Relat Metab Dis 1999; 23 (4): 361-5.
- Bell N, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-3.
- Björntorp P, Holm G, Rosmond R. Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet Med 1999; 16 (5):373-83.
- Bordelon P, Ghetu M, Langan R. Recognition and management of vitamin D deficiency. Am Fam Physician 2009; 80 (8): 841-6.
- Cannell J, Hollis B. Use of vitamin D in clinical practice. Altern Med Rev 2008; 13: 6-20.
- Cannell J, Hollis B, Zasloff M et al. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008; 9: 107-18.
- Carlin A, Rao D, Meslemani A et al. Prevalence of vitamin D depletion among morbidly obese patients sеeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98-103.
- Carrasco F, Ruz M, Rojas P et al. Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg 2009; 19: 41-6.
- Coates P, Fernstrom J, Fernstrom M et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004; 89 (3): 1061-5.
- Collazo-Clavell M, Jimenez A, Hodgson S et al. Osteomalacia after Rouxen-Y gastric bypass. Endocrine Practice 2004; 10: 287-8.
- Cundy T, Evans M, Kay R et al. Effects of vertical - banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg 1996; 83 (10): 1468-72.
- Dagogo-Jack S, Tykodi G, Umamaheswaran I. Inhibition of Cortisol Biosynthesis Decreases Circulating Leptin Levels in Obese Humans. J Clin Endocrinol Metab 2005; 90 (9): 5333-5.
- De Prisco C, Levine S. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Scien 2005; 329 (2): 57-60.
- Dolan K, Hatzifotis M, Newbury L et al. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004; 14: 165-9.
- Eddy R. Metabolic bone disease after gastrectomy. Am J Med 1971; 50: 442-9.
- Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4823-43.
- Fleischer J, Stein E, Bessler M et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab 2008; 93 (10): 3735-40.
- Freedman D, Ron E, Ballard-Barbash R et al. Body mass index and all - cause mortality in a nationwide US cohort. Int J Obes (Lond) 2006; 30: 822-9.
- Gasteyger Ch, Suter M, Gaillard R et al. Nutritional deficiencies after Rouxen-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation Am J Clin Nutr 2008; 87: 1128-33.
- Gastrointestinal surgery for severe obesity. NIH Consensus Statement Online 1991; 9 (1): 1-20.
- Giusti V, Gasteyger C, Suter M et al. Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow - up. Int J Obes (Lond) 2005; 29 (12): 1429-35.
- Gómez-Ambrosi J, Rodríguez A, Catalán V et al. The bone - adipose axis in obesity and weight loss. Obes Surg 2008; 28: 1134-43.
- Goldner W, O’Dorisio T, Dillon J et al. Severe metabolic bone disease as a long - term complication of obesity surgery. Obes Surg 2002; 12: 685-92.
- Goode L, Brolin R, Chowdhury H et al. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004; 12 (1): 40-7.
- Grey A, Bolland M, Gamble G et al. The peroxisome proliferator - activated receptor - gamma agonist rosiglitazone decreased bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2007; 92 (4): 1305-10.
- Guney E, Kisakol G, Ozgen G et al. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003; 13 (3): 383-8.
- Hamoui N, Kim K, Anthone G, Crookes P. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891-7.
- Haria D, Sibonga J, Taylor H. Hypocalcemia, hypovitaminosis D osteopathy, osteopenia, and secondary hyperparathyroidism 32 years after jejunoileal bypass. Endocrin Pract 2005; 11: 335-40.
- Hofbauer L, Gori F, Riggs B et al. Stimulation of steoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis. Endocrinology 1999; 140 (10): 4382-9.
- Interdisciplinary European guidelines for surgery for severe (morbid) obesity. Obes Surg 2007; 17: 260-70.
- Johnson J, Maher J, Samuel I et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005; 9 (8): 1106-10.
- Johnson M, Maher J, De Maria E et al. The Long - term Effects of Gastric Bypass on Vitamin D Metabolism. Ann Surg 2006; 243: 701-5.
- Lagunova Z, Porojnicu A, Lindberg F et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009; 29 (9): 3713-20.
- Li X, Jin L, Cui Q et al. Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 2005; 16 (1): 101-8.
- Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrin Rev 2001; 22: 477-501.
- Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002; 6 (5): 690-8.
- Mason M, Jalagani H, Vinik A. Metabolic complications of bariatric surgery: diagnosis and management issues. Gastroenterol Clin N Am 2005; 34: 25-33.
- Mc Gill A, Stewart J, Lithander F et al. Relationships of low serum vitamin D3 with anthropometry and markers of metabolic syndrome and diabetes in overweight and obesity. Nut J 2008; 7: 4.
- Newbury L, Dolan K, Hatzifotis M. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893-5.
- Ott M, Fanti P, Malluche H et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992; 2 (4): 341-8.
- Parikh S, Edelman M, Uwaifo G et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrin Metab 2004; 89: 1196-9.
- Pereira F, de Castro J, dos Santos J et al. Impact of marked weight loss induced by bariatric surgery on bone mineral density and remodeling. Braz J Med Biol Res 2007; 40 (4): 509-17.
- Pugnale N, Giusti V, Suter M et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese premenopausal women. Int J Obes Relat Metab Dis 2003; 27: 110-16.
- Rask E, Olsson T, Soderberg S et al. Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity. J Clin Endocrin Metab 2001; 86 (3): 1418-21.
- Rosen C, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009; 122: 409-14.
- Sánchez-Hernández J, Ybarra J, Gich I et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 2005; 15: 1389-95.
- Skroubis G, Sakellapoulos G, Pouggouras K et al. Comparison of nutritional deficiencies after Rouxen-Y gastric bypass and after biliopancreatic diversion with Rouxen-Y gastric bypass. Obes Surg 2002; 12: 551-8.
- Soleymania T, Tejavanijaa S, Morganb S. Obesity, bariatric surgery, and bone. Cur Opin Rheumatol 2011; 23: 396-405.
- Sul H. Minireview: Pref-1: Role in Adipogenesis and Mesenchymal Cell Fate. Molecular Endocrin 2009; 23 (11): 1717-25.
- Tsiftsis D, Mylonas P, Mead N et al. Bone mass decreases in morbidly obese women after long limb - biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss? Obes Surg 2009; 19 (11): 1497-503.
- Valderas J, Velasco S, Solari S et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long - term after Rouxen-Y gastric bypass. Obes Surg 2009; 19 (8): 1132-8.
- Vilarrasa N, Gomez J, Elio I et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 2009; 19 (7): 860-6.
- Von Mach M, Stoeckli R, Bilz S et al. Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 2004; 53 (7): 918-21.
- Williams S, Licata A. Severe metabolic bone disease in a 76-year - old woman thirty - three years after bariatric surgery. J Clin Densitom 2008; 11: 459.
- Worthman J, Matsuoka L, Chen T et al. Decreased bioavaillability of vitamin D in obesity. Am J Clin Nut 2000, 72: 690-3.
- Youssef Y, Richards W, Sekhar N et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007; 21: 1393-6.